Stay updated on AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Sign up to get notified when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.

Latest updates to the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page
- Check3 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3, reflecting a new version of the page template or documentation, while the study details remain unchanged.SummaryDifference0.0%

- Check10 days agoChange DetectedA new publication citation was added under Publications, listing authors and bibliographic details for a 2026 JACC CardioOncology article on differential transthyretin stabilization in transthyretin amyloidosis. This updates the study's related literature references.SummaryDifference0.0%

- Check17 days agoChange DetectedThe study page now signals that recruitment has ended and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment label is reformatted, and the revision tag updated to v3.6.0.SummaryDifference0.2%

- Check24 days agoChange DetectedA new 2026 Fontana et al. publication citation was added to the Publications section, extending the study's referenced literature. The revision history shows an update to version 3.5.5, replacing the previous v3.5.4 entry.SummaryDifference0.1%

- Check46 days agoChange DetectedA new publication citation regarding acoramidis in ATTR-CM was added to Publications, and the page revision was updated to v3.5.4 (replacing the prior v3.5.3).SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG10 Efficacy & Safety in ATTRibute-CM Clinical Trial page.